Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregor Verhoef

Showing results (41-50 of 95) with videos related to

Pageof 10
Sort By:
Hematology (Amsterdam, Netherlands)|September 18, 2012
Darbepoetin alfa administration in patients with non-Hodgkin lymphoma and chemotherapy-induced anemia receiving (±R) CHOPRuth Pettengell, Antonio Salar Silvestre, Matthias Schwenkglenks, et al.
Leukemia & Lymphoma|February 9, 2016
Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsyOlivier Gheysens, Sanne Thielemans, Julie Morscio, et al.
Blood|March 1, 2003
Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantationKaroline Spaepen, Sigrid Stroobants, Patrick Dupont, et al.
Leukemia & Lymphoma|October 12, 2022
[<sup>18</sup>F]FDG-PET/CT volumetric parameters can predict outcome in untreated mantle cell lymphomaVibeke K J Vergote, Gregor Verhoef, Ann Janssens, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 15, 2025
Divergent prognostic utility of metabolic risk scores in large B-cell lymphoma subtypes: a real-world analysisVibeke K J Vergote, Gregor Verhoef, Ann Janssens, et al.
Leukemia & Lymphoma|June 18, 2020
Open-Label, phase 2 study of blinatumomab as second salvage therapy in adults with relapsed/refractory aggressive B-cell non-Hodgkin lymphomaLuke Coyle, Nicholas J Morley, Alessandro Rambaldi, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 2, 2023
Characteristics and Outcome of Post-Transplant Lymphoproliferative Disorders After Solid Organ Transplantation: A Single Center Experience of 196 Patients Over 30 YearsVibeke K J Vergote, Christophe M Deroose, Steffen Fieuws, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2024
International Metabolic Prognostic Index Is Superior to Other Metabolic Tumor Volume-Based Prognostication Methods in a Real-Life Cohort of Diffuse Large B-Cell LymphomaVibeke K J Vergote, Gregor Verhoef, Ann Janssens, et al.
Journal of Hematopathology|June 5, 2018
Secondary B-cell lymphoma associated with the Epstein-Barr virus in chronic lymphocytic leukemia patientsJulie Morscio, Emilie Bittoun, Nathalie Volders, et al.
Haematologica|October 3, 2009
T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune responsePeter Van Loo, Thomas Tousseyn, Vera Vanhentenrijk, et al.
Pageof 10

Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
Hematology (Amsterdam, Netherlands)|September 18, 2012
Darbepoetin alfa administration in patients with non-Hodgkin lymphoma and chemotherapy-induced anemia receiving (±R) CHOPRuth Pettengell, Antonio Salar Silvestre, Matthias Schwenkglenks, et al.
Leukemia & Lymphoma|February 9, 2016
Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsyOlivier Gheysens, Sanne Thielemans, Julie Morscio, et al.
Blood|March 1, 2003
Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantationKaroline Spaepen, Sigrid Stroobants, Patrick Dupont, et al.
Leukemia & Lymphoma|October 12, 2022
[<sup>18</sup>F]FDG-PET/CT volumetric parameters can predict outcome in untreated mantle cell lymphomaVibeke K J Vergote, Gregor Verhoef, Ann Janssens, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 15, 2025
Divergent prognostic utility of metabolic risk scores in large B-cell lymphoma subtypes: a real-world analysisVibeke K J Vergote, Gregor Verhoef, Ann Janssens, et al.
Leukemia & Lymphoma|June 18, 2020
Open-Label, phase 2 study of blinatumomab as second salvage therapy in adults with relapsed/refractory aggressive B-cell non-Hodgkin lymphomaLuke Coyle, Nicholas J Morley, Alessandro Rambaldi, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 2, 2023
Characteristics and Outcome of Post-Transplant Lymphoproliferative Disorders After Solid Organ Transplantation: A Single Center Experience of 196 Patients Over 30 YearsVibeke K J Vergote, Christophe M Deroose, Steffen Fieuws, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2024
International Metabolic Prognostic Index Is Superior to Other Metabolic Tumor Volume-Based Prognostication Methods in a Real-Life Cohort of Diffuse Large B-Cell LymphomaVibeke K J Vergote, Gregor Verhoef, Ann Janssens, et al.
Journal of Hematopathology|June 5, 2018
Secondary B-cell lymphoma associated with the Epstein-Barr virus in chronic lymphocytic leukemia patientsJulie Morscio, Emilie Bittoun, Nathalie Volders, et al.
Haematologica|October 3, 2009
T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune responsePeter Van Loo, Thomas Tousseyn, Vera Vanhentenrijk, et al.
Pageof 10